Biotechnology
IMMP
1.50
price down icon6.83%   -0.11
after-market Dopo l'orario di chiusura: 1.52 0.02 +1.33%

Immutep Limited Adr (IMMP)
full-star
loading
Panoramica Notizia Cronologia dei prezzi Catena di opzioni Forum Previsione Frazionamento azionario
Precedente Chiudi:
$1.61
Aprire:
$1.59
Volume 24 ore:
173.42K
Relative Volume:
2.31
Capitalizzazione di mercato:
$218.34M
Reddito:
-
Utile/perdita netta:
-
Rapporto P/E:
-6.6756
EPS:
-0.2247
Flusso di cassa netto:
-
1 W Prestazione:
-19.35%
1M Prestazione:
-16.67%
6M Prestazione:
-26.83%
1 anno Prestazione:
-45.65%
Intervallo 1D:
Value
$1.45
$1.61
Intervallo di 1 settimana:
Value
$1.45
$1.88
Portata 52W:
Value
$1.45
$3.335

Immutep Limited Adr Stock (IMMP) Company Profile

Name
Nome
Immutep Limited Adr
Name
Settore
Healthcare (1162)
Name
Industria
Biotechnology (673)
Name
Telefono
-
Name
Indirizzo
-
Name
Dipendente
44
Name
Cinguettio
Name
Prossima data di guadagno
2025-02-24
Name
Ultimi documenti SEC
Name
IMMP's Discussions on Twitter

Confronta IMMP con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
IMMP
Immutep Limited Adr
 1.50 218.34M 0 0 0 0.00
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
 474.62 121.88B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
 573.45 62.69B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
 555.11 33.86B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
 235.74 30.51B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
 238.51 25.69B 3.81B -644.79M -669.77M -6.24

Immutep Limited Adr Stock (IMMP) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2024-05-17 Iniziato CapitalOne Overweight
2023-08-03 Iniziato Robert W. Baird Outperform
2021-08-03 Iniziato Ladenburg Thalmann Buy
2021-07-16 Ripresa Maxim Group Buy
2018-09-28 Iniziato B. Riley FBR Buy
2018-02-15 Reiterato Maxim Group Buy
Mostra tutto

Immutep Limited Adr Borsa (IMMP) Ultime notizie

pulisher
Apr 02, 2025

Immutep to Participate in Upcoming Investor Conferences - GlobeNewswire Inc.

Apr 02, 2025
pulisher
Mar 24, 2025

Immutep Limited (ASX:IMM) Initiates Phase III Trial for Non-Small Cell Lung Cancer - thecapitalclub.com.au

Mar 24, 2025
pulisher
Jan 14, 2025

Immutep Limited (NASDAQ:IMMP) Shares Sold by Jane Street Group LLC - Defense World

Jan 14, 2025
pulisher
Dec 18, 2024

Verition Fund Management LLC Has $57,000 Stock Position in Immutep Limited (NASDAQ:IMMP) - Defense World

Dec 18, 2024
pulisher
Dec 17, 2024

Immutep Announces Initial Safety Data from First-in-Human Phase I Trial Evaluating IMP761 - The Manila Times

Dec 17, 2024
pulisher
Dec 12, 2024

Immutep shares new cancer study results - Investing.com

Dec 12, 2024
pulisher
Oct 29, 2024

Immutep Quarterly Activities Report Q1 FY25 - Yahoo Finance

Oct 29, 2024
pulisher
Oct 17, 2024

Immutep Announces First-in-Human Phase I Study of IMP761 Progresses to Dose Escalation Portion of Trial - The Manila Times

Oct 17, 2024
pulisher
Sep 17, 2024

Immutep reports positive results in cancer study - Investing.com

Sep 17, 2024
pulisher
Aug 01, 2024

Immutep reports steady progress in Q4 FY24 By Investing.com - Investing.com Australia

Aug 01, 2024
pulisher
Jul 22, 2024

Immutep Announces Successful Meeting with FDA on Phase III Design in Non-Small Cell Lung Cancer - GlobeNewswire

Jul 22, 2024
pulisher
Jun 27, 2024

Baird cuts Immutep stock target on phase 2b trial results, retains Outperform - Investing.com

Jun 27, 2024
pulisher
Apr 18, 2024

Immutep Appoints Leading Research Institute to Conduct First-in-Human Phase I Study of IMP761 - GlobeNewswire

Apr 18, 2024
pulisher
Feb 05, 2024

10 Best Australian Stocks To Buy - Yahoo Finance

Feb 05, 2024
pulisher
Mar 30, 2023

Immutep Announces Expansion of Triple Combination Therapy in 1st Line Non-Small Cell Lung Cancer - GlobeNewswire

Mar 30, 2023
pulisher
Nov 03, 2022

Check Up: These 4 ASX healthcare stocks come with Strong Buy recommendations - Stockhead

Nov 03, 2022
pulisher
Dec 16, 2021

ICE Announces Annual Reconstitution Changes in the ICE Biotechnology Index - Business Wire

Dec 16, 2021
pulisher
Apr 08, 2021

FDA Grants Fast Track Designation to 1L Eftilagimod Alpha for Recurrent or Metastatic HNSCC - Targeted Oncology

Apr 08, 2021
pulisher
Dec 30, 2020

Best Penny Stocks To Buy For 2021? 5 Biotech Stocks To Watch - Penny Stocks

Dec 30, 2020
pulisher
Sep 06, 2020

IMMPImmutep Latest Stock News & Market Updates - Stock Titan

Sep 06, 2020
pulisher
Jul 15, 2020

The Daily Biotech Pulse: Moderna To Kickstart Phase 3 Study On July 27, Immutep Awarded Antibody Patent - Yahoo Finance

Jul 15, 2020
pulisher
Jun 01, 2018

Benzinga's Daily Biotech Pulse: Organovo Falls On Earnings; Celgene Gets New CFO - Yahoo Finance

Jun 01, 2018
pulisher
Dec 10, 2017

A Full List of Australia ADRs - Investing.com Australia

Dec 10, 2017
pulisher
Dec 05, 2017

Immutep (IMMP) Stock Price, News & Analysis - MarketBeat

Dec 05, 2017

Immutep Limited Adr Azioni (IMMP) Dati Finanziari

Non sono disponibili dati finanziari per Immutep Limited Adr (IMMP). Controlla altri titoli per ulteriori informazioni.

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading

Simile a IMMP

biotechnology INCY
$60.58
price down icon 3.01%
biotechnology INSM
$69.18
price down icon 5.66%
biotechnology SMMT
$17.36
price down icon 8.20%
biotechnology RPRX
$31.11
price down icon 2.14%
biotechnology BNTX
$88.05
price down icon 4.30%
biotechnology ONC
$238.51
price down icon 9.76%
Apri su Yahoo | Apri su Google | Aperto in Finviz | Apri in MarketWatch | Aperto a EDGAR | Aperto su Reuters
Capitalizzazione:     |  Volume (24 ore):